Perrigo Ordinary Shares reported $-16200000 in Operating Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbott ABT:US $ 2388M 524M
Abbvie ABBV:US $ 3295M 1422M
Bayer BAYN:GR 169M 4.04B
Bristol Myers Squibb BMY:US $ 2590M 37M
Catalent CTLT:US $ 211M 50M
Coherus Biosciences CHRS:US $ -44.01M 43.13M
Corcept Therapeutics CORT:US $ 31.43M 4.66M
Dr.Reddys Laboratories DRRD:IN 6.39B 4.81B
Eli Lilly And LLY:US $ 1210.1M 1194.2M
Horizon Pharma HZNP:US $ 88.56M 105.76M
Johnson & Johnson JNJ:US $ 5840M 22M
Lannett LCI:US $ -22.08M 46M
Merk MRK:US $ 4927M 642M
Pacira Pharmaceuticals PCRX:US $ 31.24M 13.84M
Perrigo Ordinary Shares PRGO:US $ -16.2M 37.9M
Pfizer PFE:US $ 12102M 2229M
Phibro Animal Health PAHC:US $ 19.19M 3.1M
Prestige Brands PBH:US $ 87.01M 9.59M
Supernus Pharmaceuticals SUPN:US $ 11.35M 9.38M
Teva Pharmaceutical TEVA:IT -949000000 236M
Xeris Pharmaceuticals Inc XERS:US $ -18916000 10.16M
Zoetis ZTS:US $ 670M 57M